28 Consultants Ltd

Holdings History for CytoMed Therapeutics Ltd - Ordinary Shares (GDTC)

Symbol: GDTC on Nasdaq
Investment type: Equity / Ordinary Shares
Latest Disclosed Shares Owned: 880,313 shares
Security Ownership %: 7.6%

28 Consultants Ltd ownership in CytoMed Therapeutics Ltd Ordinary Shares (GDTC)

04 Mar 2025 - 28 Consultants Ltd has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 880,313 shares of CytoMed Therapeutics Ltd Ordinary Shares (GDTC). This represents 7.6% ownership of the company. This is the first filing by 28 Consultants Ltd disclosing ownership of CytoMed Therapeutics Ltd Ordinary Shares (GDTC).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
28 Consultants Ltd	7.6%		$2,095,145	880,313			$2.38	13G	17 Feb 2025	04 Mar 2025, 15:33